Browse drugs

…educe reliance on loop diuretics where appropriate and increase dapagliflozin uptake. A planned 12-month re-audit will assess sustainability …

…d 6–8 weeks after transplantation and randomised 1:1 to receive dapagliflozin 10 mg/day or placebo for 3 years. Recipients with conditions th…

…wed no significant differences between sacubitril/valsartan and dapagliflozin (win ratio, 1.15; 95% CI 0.71 to 1.88), or between torsemide an…

…le patients will be randomised in a 1:1 ratio to receive either dapagliflozin (10 mg once daily) or a matching placebo for a duration of 1 ye…

… phenotypes and to explore potential immunometabolic effects of dapagliflozin in lupus nephritis.Methods Thirty-six female SLE patients were …

…ple with T2DM and established CVD to receive either the SGLT2i, empagliflozin, or placebo.5 To be eligible for this study, people had to meet…

…n renal interstitial fibrosis (p≤0.0001), compared to controls. Dapagliflozin attenuated serum BUN (p≤0.01) and creatinine (p≤0.01) but did n…

…, whereby researchers are investigating the use of subcutaneous semaglutide 2.4 mg/week for the treatment of adults with non-cirrhotic MASH…

…ient, with ICERs generally below willingness-to-pay thresholds. Dapagliflozin was cost saving in type 2 diabetes (T2D) in the United Kingdom …

…ng renin-angiotensin-aldosterone system inhibitors (RAASi) with dapagliflozin compare to RAASi alone in children with hereditary kidney disea…

…), 0.3 days for Dapagliflozin (95%CI 0.4–0.2), and 0.3 days for Alendronic Acid (95%CI 0.4–0.2).Dispensing practices more consistently prescrib…

…=111,357; e.g., empagliflozin, dapagliflozin, canagliflozin) or DPP4is (n=43,868; e.g., sitagliptin, linagliptin) without cross-exposu…